VGT-309: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
Created page with ''''VGT-309''' is an experimental "Cathepsin-Targeted Quenched Activity-Based Probe" designed to highlight cancers for fluorescence guided surgery.<ref>{{cite journal |last1=Suurs |first1=Frans V. |last2=Qiu |first2=Si-Qi |last3=Yim |first3=Joshua J. |last4=Schröder |first4=Carolien P. |last5=Timmer-Bosscha |first5=Hetty |last6=Bensen |first6=Eric S. |last7=Santini |first7=John T. |last8=de Vries |first8=Elisabeth G. E. |last9=Bogyo |first9=Matt...'
(No difference)

Revision as of 05:43, 23 November 2023

VGT-309 is an experimental "Cathepsin-Targeted Quenched Activity-Based Probe" designed to highlight cancers for fluorescence guided surgery.[1][2][3]

References

  1. ^ Suurs, Frans V.; Qiu, Si-Qi; Yim, Joshua J.; Schröder, Carolien P.; Timmer-Bosscha, Hetty; Bensen, Eric S.; Santini, John T.; de Vries, Elisabeth G. E.; Bogyo, Matthew; van Dam, Gooitzen M. (29 September 2020). "Fluorescent image-guided surgery in breast cancer by intravenous application of a quenched fluorescence activity-based probe for cysteine cathepsins in a syngeneic mouse model". EJNMMI Research. 10 (1): 111. doi:10.1186/s13550-020-00688-0. ISSN 2191-219X.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  2. ^ Santiago, Nicole Lugo; Wen, Wei; Kohut, Adrian; Bensen, Eric; Santini, John; Yim, John; Fong, Yuman; Han, Ernest (1 August 2022). "Preclinical evaluation of a novel cathepsin-activated fluorescent probe VGT-309 for identification of ovarian cancer in a mouse model (248)". Gynecologic Oncology. 166: S134. doi:10.1016/S0090-8258(22)01471-8. ISSN 0090-8258.
  3. ^ Kennedy, Gregory T.; Holt, David E.; Azari, Feredun S.; Bernstein, Elizabeth; Nadeem, Bilal; Chang, Ashley; Sullivan, Neil T.; Segil, Alix; Desphande, Charuhas; Bensen, Eric; Santini, John T.; Kucharczuk, John C.; Delikatny, Edward J.; Bogyo, Matthew; Egan, A. J. Matthew; Bradley, Charles W.; Eruslanov, Evgeniy; Lickliter, Jason D.; Wright, Gavin; Singhal, Sunil (1 September 2022). "A Cathepsin-Targeted Quenched Activity-Based Probe Facilitates Enhanced Detection of Human Tumors during Resection". Clinical Cancer Research: An Official Journal of the American Association for Cancer Research. 28 (17): 3729–3741. doi:10.1158/1078-0432.CCR-22-1215. ISSN 1557-3265.